Sterling Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.04K Sell
121
-97
-44% -$8.21K ﹤0.01% 2343
2026
Q1
$21.7K Sell
218
-4
-2% -$522 ﹤0.01% 1991
2025
Q4
$27K Buy
222
+141
+174% +$17.7K ﹤0.01% 2071
2025
Q3
$9.09K Buy
81
+1
+1% +$117 ﹤0.01% 2537
2025
Q2
$10.7K Buy
80
+45
+129% +$4.94K ﹤0.01% 2086
2025
Q1
$2.35K Buy
35
+2
+6% +$138 ﹤0.01% 2530
2024
Q4
$2.06K Hold
33
﹤0.01% 2777
2024
Q3
$5.18K Buy
+33
New +$5.08K ﹤0.01% 1749

Other funds holding TMDX

Sterling Capital Management's TMDX Position: Q2 2026 in Review

Sterling Capital Management reduced its Transmedics (TMDX) stake by 44% in Q2 2026, selling an estimated $8.21K and leaving 121 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

Sterling Capital Management first reported a position in TMDX in Q3 2024 and has held it in 8 quarters since. The position peaked at $27K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Sterling Capital Management held 121 shares of Transmedics worth $8.04K as of Q2 2026.
  • Sterling Capital Management sold 97 Transmedics shares in Q2 2026, an estimated $8.21K.
  • Transmedics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2343 holding.
  • Sterling Capital Management first reported a position in Transmedics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Transmedics position peaked at $27K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.